Pitt Spinout Company, Oncorus, Moves Forward
Oncorus, Inc., is a viral immunotherapies company founded in 2016 [...]
Illumination of Immune Checkpoint LAG3 ‘Black Box’ Could Yield New Cancer and Autoimmune Therapies
Fighting cancer and chronic disease is tiring work for the [...]
Welcome: Dr. Hamza Yazdani
The McGowan Institute for Regenerative Medicine welcomes new affiliated faculty [...]
Funding to Advance the Pittsburgh Center for Interdisciplinary Bone and Mineral Research
The multidisciplinary team consisting of seven McGowan Institute for Regenerative [...]
Dr. Kurt Weiss Named MIB Agents’ 2021 OutSmarting Osteosarcoma Research Grant Winner
Congratulations to McGowan Institute for Regenerative Medicine affiliated faculty member [...]
Researchers Discover New Way to Target Secondary Breast Cancer that Has Spread to the Brain
An international collaborative study by researchers at Royal College of [...]
Novel Computational Pipeline Could Help Repurpose Cancer Drugs for Rare Diseases
By combining computational and experimental approaches, University of Pittsburgh School [...]
Molecular Atlas of Senescent Cells Could Chart Way to Therapies for Age-Related Diseases and Cancer
Most cells throughout the body can divide and multiply to [...]
Research Offers New Insight for Treating Aggressive Form of Breast Cancer
An international team of researchers—including McGowan Institute for Regenerative Medicine [...]
Dr. Howard Edington Offers T-VEC Injections for Some Patients with Advanced Melanoma
Paul Kirsch of Greentree is a retired U.S. Marine and [...]